Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma

NCT: NCT04542616 · COMPLETED

NCT IDNCT04542616

StatusCOMPLETED

Start Date2020-08-13

Completion2024-07-31

Brief Summary

To compare the safety and efficacy of Baerveldt 350 and Ahmed ClearPath 250 tube shunts in lowering IOP in glaucoma patients.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑